Feeds

Two drug trial victims released

But one still critical

High performance access to file storage

Doctors caring for the six human guinea pig victims of the disastrous TeGenero drug trial have discharged two of the men. Three others remain as in-patients at Northwick Park Hospital, London, while one man is still in a critical condition after being administered an experimental immune treatment more than two weeks ago.

The hospital is staying tight-lipped on the prognosis for the critical patient, but says he has shown some signs of improvement. The released volunteers will continue to receive treatment and be monitored as out-patients.

The men were given TGN1412, an antibody designed to suppress the destructive power of immune cells in diseases like rheumatoid arthritis and leukaemia. The problems didn't show up in animal trials.

Speculations about what caused the reaction have centred on contamination of the doses by bacterial toxins, and a paradoxical super-activation of the volunteer's immune system.®

High performance access to file storage

More from The Register

next story
Elon Musk's LEAKY THRUSTER gas stalls Space Station supply run
Helium seeps from Falcon 9 first stage, delays new legs for NASA robonaut
Solar-powered aircraft unveiled for round-the-world flight
It's going to be a slow and sleepy flight for the pilots
Russian deputy PM: 'We are coming to the Moon FOREVER'
Plans to annex Earth's satellite with permanent base by 2030
LOHAN's Punch and Judy show relaunches Thursday
Weather looking good for second pop at test flights
Saturn spotted spawning new FEMTO-MOON
Icy 'Peggy' looks to be leaving the outer rings
Discovery time for 200m WONDER MATERIALS shaved from 4 MILLENNIA... to 4 years
Alloy, Alloy: Boffins in speed-classification breakthrough
India's GPS alternative launches second satellite
Closed satnav system due to have all seven birds aloft by 2016
Curiosity finds not-very-Australian-shaped rock on Mars
File under 'messianic pastries' and move on, people
Top Secret US payload launched into space successfully
Clandestine NRO spacecraft sets off on its unknown mission
prev story

Whitepapers

Mainstay ROI - Does application security pay?
In this whitepaper learn how you and your enterprise might benefit from better software security.
Five 3D headsets to be won!
We were so impressed by the Durovis Dive headset we’ve asked the company to give some away to Reg readers.
3 Big data security analytics techniques
Applying these Big Data security analytics techniques can help you make your business safer by detecting attacks early, before significant damage is done.
The benefits of software based PBX
Why you should break free from your proprietary PBX and how to leverage your existing server hardware.
Mobile application security study
Download this report to see the alarming realities regarding the sheer number of applications vulnerable to attack, as well as the most common and easily addressable vulnerability errors.